Analysis of tumor-related survival (until tumors reached a size of 1000 mm3) revealed a median survival of 23 days in treated mice (PSMA-N064 + NIR, group 1), which was significantly prolonged compared with mice in the ligand-only control group (group 2, 8 days), mice in the irradiation-only control group (group 3, 9 days), or mice that received neither ligand nor NIR light irradiation (group 4, 7 days, p = 0.004) (Fig. 3C). Here, FOLH1 is linked to neoplasm.